ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "skin and systemic sclerosis"

  • Abstract Number: 724 • 2019 ACR/ARP Annual Meeting

    Biomechanical Properties of Skin for Assessment of Scleroderma: A Systemic Review

    Peiyun Ni1, Lilit Garibyan 2 and Rox Anderson 2, 1Harvard-MIT Health Sciences and Technology, Harvard Medical School, Boston, MA, 2Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA

    Background/Purpose: Skin involvement is one of the early features of scleroderma and an important predictor of internal organ involvement and mortality. Skin fibrosis alters the…
  • Abstract Number: 2935 • 2018 ACR/ARHP Annual Meeting

    A Practical Classification of Systemic Sclerosis Using Subset and Autoantibodies for the Purpose of Early Risk Stratification

    Svetlana I. Nihtyanova1, Emma C. Derrett-Smith2, Carmen Maria Fonseca3, Voon H. Ong2 and Christopher P. Denton4, 1Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, 2Division of Medicine, University College London, London, United Kingdom, 3Department of Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom, 4University College London, London, United Kingdom

    Background/Purpose: The Le Roy et al. classification of SSc into limited and diffuse cutaneous subtype remains the most commonly used. Nevertheless, autoantibodies are much better…
  • Abstract Number: 1741 • 2018 ACR/ARHP Annual Meeting

    Disease Duration and Autoantibodies Predict Distinct Skin Score Trajectories in Diffuse Cutaneous Systemic Sclerosis

    Svetlana I. Nihtyanova1, Alper Sari2, Voon H. Ong3 and Christopher P. Denton4, 1Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, 2Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 3Division of Medicine, University College London, London, United Kingdom, 4University College London, London, United Kingdom

    Background/Purpose: Although severity of skin involvement and change in skin thickness over time vary substantially between patients with diffuse cutaneous systemic sclerosis (dcSSc), for the…
  • Abstract Number: 756 • 2017 ACR/ARHP Annual Meeting

    Novel Machine Learning Classifier Accurately Predicts Intrinsic Molecular Subsets for Patients with Systemic Sclerosis

    Jennifer Franks1, Viktor Martyanov1, Guoshuai Cai1 and Michael L. Whitfield2, 1Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 2Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH

    Background/Purpose: High-throughput gene expression profiling of skin biopsies from patients with systemic sclerosis (SSc) has identified four “intrinsic” gene expression subsets conserved across multiple cohorts…
  • Abstract Number: 3000 • 2014 ACR/ARHP Annual Meeting

    Comparison of Systemic Sclerosis Subsets As Predictors of Mortality and Morbidity

    Hebah Alhajeri1, Marie Hudson2,3, Canadian Scleroderma Research Group CSRG4 and Murray Baron5, 1Rheumatology, McGill University, Montreal, QC, Canada, 2Rheumatology, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, 3Division of Rheumatology, McGill University, Montreal, QC, Canada, 4McGill University, Montreal, QC, Canada, 5Pavillion A, Rm 216, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada

    Background/Purpose: Identifying systemic sclerosis (SSc) subsets that predict mortality and morbidity could provide useful prognostic information. We undertook this study to compare the predictive ability…
  • Abstract Number: 2721 • 2014 ACR/ARHP Annual Meeting

    Patients’ Perspective of Skin Involvement in Systemic Sclerosis

    Ada Man1, Amy Wu1, Jessica Ziemek2, Romy Christmann1, Robert W. Simms1, David T. Felson3 and Robert Lafyatis4, 1Rheumatology, Boston University School of Medicine, Boston, MA, 2Rheumatology/Arthritis Center, Boston University School of Medicine, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Arthritis Center, Boston University, Boston, MA

    Background/Purpose:   Skin tightness and other abnormalities of the skin are the hallmark features of systemic sclerosis (SSc).  While skin involvement may significantly impact a…
  • Abstract Number: 2713 • 2014 ACR/ARHP Annual Meeting

    The Relationship of Patient Reported Skin Symptoms to the Scleroderma HAQ, the Modified Rodnan Skin Score and Skin Pathology. 

    Jessica Ziemek1, Ada Man2, Robert W. Simms2 and Robert Lafyatis2, 1Rheumatology/Arthritis Center, Boston University School of Medicine, Boston, MA, 2Rheumatology, Boston University School of Medicine, Boston, MA

    Background/Purpose: Changes in skin are a cardinal feature of systemic sclerosis (SSc). However, there are no SSc specific patient reported outcome measures validated for use…
  • Abstract Number: 1887 • 2014 ACR/ARHP Annual Meeting

    Genome-Wide DNA Methylation Analysis of Twin Pairs Discordant for Systemic Sclerosis Reveals Distinct Signatures in Blood and Dermal Fibroblasts

    Paula S. Ramos1, Rick Jordan2, James Lyons-Weiler2, Thomas A. Medsger Jr.3 and Carol A. Feghali-Bostwick4, 1Department of Medicine, Medical University of South Carolina, Charleston, SC, 2Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, 3Medicine/Rheumatology, University of Pittsburgh, Pittsburgh, PA, 4Medicine, Medical University of South Carolina, Charleston, SC

    Background/Purpose Systemic sclerosis (SSc) is a chronic, multisystem, autoimmune inflammatory disease with genetic and non-genetic contributions to risk. The etiology of SSc, including the reasons…
  • Abstract Number: 2915 • 2013 ACR/ARHP Annual Meeting

    Effect Of Menopause On Skin Thickening In Systemic Sclerosis

    Evelyne Vinet1, Sasha Bernatsky2, Christian A. Pineau3, Marie Hudson4, Murray Baron5 and the Canadian Scleroderma Research Group6, 1McGill University Health Center, Montreal, QC, Canada, 2Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada, 3Rheumatology, McGill University Health Center, Montreal, QC, Canada, 4Rheumatology, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, 5McGill University, Montreal, QC, Canada, 6McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Menopause, characterized by a low estrogenic state, is associated with skin thinning, due to decreased extracellular matrix protein deposition by fibroblasts. Although systemic sclerosis…
  • Abstract Number: 2602 • 2013 ACR/ARHP Annual Meeting

    Reduced Frequencies Of Circulating CD8 T Cells In Early Diffuse Cutaneous Systemic Sclerosis Is Associated With Worse Skin Scores

    Marie Hudson1, Maximilien Lora2, Christopher Di Ioia3, Solene Tatibouet4, Sasha Bernatsky5 and Ines Colmegna6, 1Rheumatology, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, 2Rheumatology, McGill University Health Centre, Montréal, QC, Canada, 3McGill University, Montreal, QC, Canada, 4Jewish General Hospital, McGill University, Montreal, QC, Canada, 5Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada, 6Rheumatology, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Diffuse cutaneous systemic sclerosis (dcSSc) is associated with significant morbidity and mortality. Measurement of skin thickness (modified Rodnan skin score (mRss)) is a surrogate…
  • Abstract Number: 2604 • 2013 ACR/ARHP Annual Meeting

    Longitudinal Assessment Of Scleroderma Skin By Optical Coherence Tomography: Preliminary Validation Of Sensitivity To Change Over-Time

    Giuseppina Abignano1, Lesley-Anne Bissell1, Jason Britton2, Daniel Woods3, Maya H. Buch1, Dennis McGonagle1, Paul Emery1 and Francesco Del Galdo1, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 2Medical Physics Department, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 3Michelson Diagnostics Ltd, Kent, United Kingdom

    Background/Purpose: Optical coherence tomography (OCT) has been shown to be a quantitative reliable tool to assess skin involvement in Systemic Sclerosis (SSc) (1). However the…
  • Abstract Number: 2573 • 2013 ACR/ARHP Annual Meeting

    The Role Of STAT-3 In The Development Of Pulmonary and Dermal Fibrosis

    Mesias Pedroza1, Sarah To1, Anuh T. George1, David J. Tweardy2 and Sandeep K. Agarwal1, 1Medicine, Section of Immunology, Allergy and Rheumatology, Baylor College of Medicine, Houston, TX, 2Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX

    Background/Purpose: Fibrosis is the accumulation of excessive extra-cellular matrix in tissues, leading to tissue damage.  In systemic sclerosis, the trigger is postulated to be an…
  • Abstract Number: 2569 • 2013 ACR/ARHP Annual Meeting

    Serum S100A4 Levels Correlate With Skin Fibrosis and Lung Involvement In Systemic Sclerosis

    Michal Tomcik1, Lucie Andres Cerezo1, Simona Skacelova2, Martin Komarc3, Radim Becvar1, Mariam Grigorian4, Joerg HW Distler5 and Ladislav Senolt1, 1Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 2Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Prague, Czech Republic, 3Institute of Biophysics and Informatics of the First Faculty of Medicine, Charles University, Prague, Czech Republic, 4Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark, 5Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany

    Background/Purpose: Our previous study demonstrated that S100A4 is overexpressed in scleroderma (SSc) skin, fibroblasts and preclinical models of SSc in a TGF-β dependent manner. Furthermore,…
  • Abstract Number: 702 • 2013 ACR/ARHP Annual Meeting

    Prediction Of Worsening Of Skin Fibrosis In Patients With Diffuse Systemic Sclerosis Using The EULAR Scleroderma Trials and Research (EUSTAR) Registry

    Britta Maurer1, Nicole Graf2, Beat A. Michel3, Carola Metzig4, Vivian Lanius4, Dinesh Khanna5 and Oliver Distler1, 1Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2graf biostatistics, Winterthur, Switzerland, 3Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 4Bayer Pharma AG, Berlin, Germany, 5University of Michigan Health System, Ann Arbor, MI

    Background/Purpose: To identify predictive parameters for the progression of skin fibrosis in patients with diffuse cutaneous SSc (dcSSc) to enable 1) risk-stratification in clinical practice…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology